Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Palatin Technologies, Inc. (PTN)

Kiora Pharmaceuticals, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Palatin Technologies, Inc. are of similar size ($11.6M and $10.7M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against 110.9%. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −63.5%) and the lower return on invested capital (−44,053.9% vs 0.00%). Across the 17 metrics below, Kiora Pharmaceuticals, Inc. leads on 11 and Palatin Technologies, Inc. on 6.

Valuation

Metric KPRX PTN Biotechnology median
P/E n/m n/m 8.50
P/S 0.79 1.29 9.71
P/B 0.88 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales (0.10) 0.73 9.21
Earnings yield (103.07%) (49.33%) (33.15%)
Free cash flow yield (58.10%) (79.85%) (25.50%)

Profitability

Metric KPRX PTN Biotechnology median
Gross margin 85.06% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (56.36%) (877.60%) (56.36%)
Return on assets (39.43%) (142.11%) (48.04%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX PTN Biotechnology median
Revenue growth (TTM) 983.73% 110.89% 6.02%
EPS growth (last fiscal year) (403.45%) 90.79% 30.26%
Revenue growth, 5-year CAGR 88.72% 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 4.61 4.72
Net debt to EBITDA 1.33 0.87 0.96

Dividend

Metric KPRX PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KPRX PTN Biotechnology median
Market cap 10.66m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack